Your browser doesn't support javascript.
loading
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors.
Falanga, Anna; Marchetti, Marina; Massi, Daniela; Merelli, Barbara; Verzeroli, Cristina; Russo, Laura; Rulli, Eliana; Tondini, Carlo; Legramandi, Lorenzo; Nassini, Romina; Scatena, Cristian; De Logu, Francesco; Cattaneo, Laura; Mandalà, Mario.
Afiliação
  • Falanga A; Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Marchetti M; Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Massi D; Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
  • Merelli B; Unit of Medical Oncology, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Verzeroli C; Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Russo L; Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Rulli E; Department of Oncology, Clinical Research Laboratory, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri," Milan, Italy.
  • Tondini C; Unit of Medical Oncology, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Legramandi L; Department of Oncology, Clinical Research Laboratory, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri," Milan, Italy.
  • Nassini R; Unit of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Scatena C; Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
  • De Logu F; Unit of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Cattaneo L; Division of Pathological Anatomy, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Mandalà M; Unit of Medical Oncology, Hospital Papa Giovanni XXIII, Bergamo, Italy. Electronic address: mariomandala@tin.it.
J Am Acad Dermatol ; 74(6): 1254-1256.e4, 2016 Jun.
Article em En | MEDLINE | ID: mdl-27185428
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Produtos de Degradação da Fibrina e do Fibrinogênio / Trombofilia / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Produtos de Degradação da Fibrina e do Fibrinogênio / Trombofilia / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália